The accelerator hypothesis and increasing incidence of type 1 diabetes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 4, 2008, Pages 321-325

  Fourlanos, Spiros ^a   Harrison, Leonard C ^a   Colman, Peter G ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Accelerator hypothesis; Insulin resistance; Type 1 diabetes

Indexed keywords

C PEPTIDE; INSULIN; NICOTINAMIDE;

APOPTOSIS; AUTOIMMUNITY; BODY WEIGHT; DISEASE COURSE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; RISK FACTOR; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; IMMUNITY, NATURAL; INCIDENCE; INSULIN RESISTANCE; ISLETS OF LANGERHANS; RISK FACTORS;

EID: 55249120245     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283073a5a     Document Type: Review

References (34)

1. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001; 44:914-922.
2. Koyama M, Wada R, Sakuraba H, et al. Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of noninsulin-dependent diabetes mellitus. Am J Pathol 1998; 153:537-545.
3. Bar-On H, Ben-Sasson R, Ziv E, et al. Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis. Pancreas 1999; 18:259-265.
4. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847-2850.
5. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes: the analysis of the data on published incidence trends. Diabetologia 1999; 42:1395-1403.
6. Gale EA. To boldly go - or to go too boldly? The accelerator hypothesis revisited. Diabetologia 2007; 50:1571-1575. This is a comprehensive revision of the accelerator hypothesis.
7. Cervin C, Lyssenko V, Bakhtadze E, et al., Genetic Similarities between Lada, type 1 and type 2 diabetes. Diabetes 2008 [Epub ahead of print]. This genetic study demonstrates shared genes in LADA and type 1 diabetes.
8. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46:3-19.
9. Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2002; 15 (Suppl 1):487-492.
10. Fourlanos S, Narendran P, Byrnes GB, et al. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004; 47:1661-1667.
11. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
12. Chase HP, Cuthbertson DD, Dolan LM, et al. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 2001; 138:244-249.
13. Xu P, Cuthbertson D, Greenbaum C, et al. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007; 30:2314-2320. This large study confirms the involvement of insulin resistance in the pathogenesis of type 1 diabetes.
14. Gale EA, Bingley PJ, Emmett CL, Collier T. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004; 363:925-931.
15. Bingley PJ, Mahon JL, Gale EA. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 2008; 31:146-150. This study demonstrates that insulin resistance could be more important in preclinical subjects with reduced beta cell function.
16. Knerr I, Wolf J, Reinehr T, et al. The 'accelerator hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 2005; 48:2501-2504.
17. Kibirige M, Metcalf B, Renuka R, Wilkin TJ. Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 2003; 26:2865-2870.
18. Baum JD, Ounsted M, Smith MA. Letter: Weight gain in infancy and subsequent development of diabetes mellitus in childhood. Lancet 1975; 2:866.
19. Johansson C, Samuelsson U, Ludvigsson J. A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1994; 37:91-94.
20. Hypponen E, Kenward MG, Virtanen SM, et al. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999; 22:1961-1965.
21. Bruining GJ. Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 2000; 356:655-656.
22. Betts P, Mulligan J, Ward P, et al. Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med 2005; 22:144-151.
23. Kordonouri O, Hartmann R. Higher body weight is associated with earlier onset of type 1 diabetes in children: confirming the 'Accelerator Hypothesis'. Diabet Med 2005; 22:1783-1784.
24. Hypponen E, Virtanen SM, Kenward MG, et al. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 2000; 23: 1755-1760.
25. Dabelea D, D'Agostino RB Jr, Mayer-Davis EJ, et al. Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care 2006; 29:290-294.
26. Caprio S, Hyman LD, Limb C, et al. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995; 269 (1 Pt 1):E118-E126.
27. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is 'syndrome X' present? J Clin Endocrinol Metab 1996; 81:1058-1062.
28. Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9:151-159.
29. Kloppel G, Lohr M, Habich K, et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985; 4:110-125.
30. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased betacell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110.
31. Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003; 88:2300-2308.
32. Campbell IL, Harrison LC. Molecular pathology of type 1 diabetes. Mol Biol Med 1990; 7:299-309.
33. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. TEDDY Study Group. Pediatr Diabetes 2007; 8: 286-298.
34. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672.